Shopping Cart
Remove All
Your shopping cart is currently empty
NCT02 is a molecular glue degrader targeting CDK12 and CCNK (cyclin K), inducing CCNK ubiquitination and inhibiting CRC cell proliferation in vivo and in vitro, leading to apoptosis and cell cycle arrest. It is intended for the investigation of metastatic colorectal cancer (CRC).

| Pack Size | Price | USA Warehouse | Global Warehouse | Quantity |
|---|---|---|---|---|
| 2 mg | $58 | - | In Stock |
| Description | NCT02 is a molecular glue degrader targeting CDK12 and CCNK (cyclin K), inducing CCNK ubiquitination and inhibiting CRC cell proliferation in vivo and in vitro, leading to apoptosis and cell cycle arrest. It is intended for the investigation of metastatic colorectal cancer (CRC). |
| In vitro | NCT02 (0-20 μM, 72 hours) exhibited low cytotoxicity toward normal fibroblasts but showed dose-dependent inhibition of cell viability in colorectal cancer cell lines (TSC03, TSC08, TSC47, etc.) [1]. NCT02 (10 μM, 24-48 hours) induced apoptosis in TSC03 and TSC14 cells, as evidenced by a significant increase in the proportion of cleaved PARP-positive cells [1]. NCT02 (10 μM, 6 hours) triggered degradation of the CCNK/CDK12 complex, leading to a marked reduction in CCNK protein levels and decreased phosphorylation of p-Ser2 POLR2 [1]. |
| Synonyms | NCT 02 |
| Molecular Weight | 312.39 |
| Formula | C17H16N2O2S |
| Cas No. | 790245-61-3 |
| Smiles | Cc1cnc(NC(=O)Cc2coc3cc4CCCc4cc23)s1 |
| Color | Yellow |
| Appearance | Solid |
| Storage | store at low temperature | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. | |||||||||||||||||||||||||||||||||||
| Solubility Information | DMSO: 40 mg/mL (128.05 mM), Sonication is recommended. | |||||||||||||||||||||||||||||||||||
Solution Preparation Table | ||||||||||||||||||||||||||||||||||||
DMSO
| ||||||||||||||||||||||||||||||||||||
| Size | Quantity | Unit Price | Amount | Operation |
|---|

Copyright © 2015-2025 TargetMol Chemicals Inc. All Rights Reserved.